News
Muna Therapeutics and GSK to accelerate development of novel treatments for Alzheimer’s disease
Muna Therapeutics, a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases, has announced a research alliance with GSK to identify and validate...
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation to advance small molecule condensate modulator for...
Dewpoint Therapeutics, the biotechnology company that develops therapeutics by targeting biomolecular condensates, has entered into a strategic research collaboration with Mitsubishi Tanabe Pharma Corporation...
Imfinzi approved in US for patients with limited-stage small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease...
